Positive Sales Growth in EMEA
Sales in EMEA increased by 15% in constant exchange rate compared to the last year, driven by strong performance in Europe, with notable growth in countries like France, U.K., and Poland.
Strong Performance of New Products
Elekta's latest linear accelerator, Elekta Evo, and the new software suite, Elekta ONE, are gaining traction, contributing positively to sales growth and customer wins.
Cash Flow Improvement
Operating cash flow after continuous investments amounted to negative SEK 361 million, an improvement by SEK 529 million year-over-year, mainly driven by improved working capital management.
FDA Clearance for Leksell Gamma Knife
The Leksell Gamma Knife received FDA clearance for treating certain types of epilepsy, expanding the scope of stereotactic radiosurgery.